USPTO Examiner DOLETSKI BLAINE G - Art Unit 1692

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19101657CONTINUOUS METHOD FOR PRODUCING N-BUTYL(METH)ACRYLATE INCLUDING A CATALYST RECIRCULATION PROCESSFebruary 2025November 2025Allow910YesNo
19022985METHODS FOR SEPARATING THE BINARY AZEOTROPIC MIXTURE OF ETHYLENE GLYCOL AND ETHYLENE GLYCOL DIACETATE WITH SULFOLANE ENTRAINERJanuary 2025August 2025Allow710NoNo
18857358PROCESS FOR RECYCLING POLYETHYLENE TEREPHTHALATE USING A GRADIENT IN IMPURITY CONCENTRATIONOctober 2024February 2026Allow1620NoNo
18724617METHOD FOR PREPARING BIS(GLYCOL)TEREPHTHALATE AND POLYESTER RESIN USING SAMEJune 2024March 2026Allow2121YesNo
18736389RAPIDLY METABOLIZED LIPID COMPOUNDJune 2024July 2025Allow1311YesNo
18714848A LIPID COMPOUND CONTAINING CARBAMATE BOND AND APPLICATIONS THEREOFMay 2024January 2025Allow710NoNo
18635160CRYSTALLINE POLYMORPHS OF RIGOSERTIB SODIUMApril 2024February 2026Allow2211NoNo
18609781Methods of producing and recovering levulinic acidMarch 2024December 2024Allow920YesNo
18689150METHOD FOR PRODUCING BIS-2-HYDROXYETHYL TEREPHTHALATE THROUGH CONTINUOUS DEPOLYMERIZATIONMarch 2024January 2026Allow2240YesNo
18687102POLYMERIZABLE RAW MATERIAL COMPRISING RECYCLED BIS(2-HYDROXYETHYL) TEREPHTHALATE AND METHOD FOR PREPARING THE SAMEFebruary 2024September 2025Allow1830NoNo
18584742SYNTHESIS PROCESS FOR HIGH PURITY ISOSULFAN BLUE USING FLASH CHROMATOGRAPHY IN COMMERCIAL PLANT SCALEFebruary 2024August 2024Allow600YesNo
18549762PROCESS FOR EXTRACTING AROMATIC DICARBOXYLIC ACIDS FROM THEIR METAL SALTSSeptember 2023August 2025Allow2330YesNo
18320517METHODS FOR PRODUCING ALKYL HYDROXYALKANOATESMay 2023November 2025Abandon3010NoNo
18312088PREPARATION METHOD FOR GLUFOSINATEMay 2023January 2026Abandon3221NoNo
18126225METHOD FOR PREPARING 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDEMarch 2023December 2025Abandon3310YesNo
18112411DERIVATIVES OF MENTHOL AND USES THEREOFFebruary 2023October 2025Abandon3231YesNo
18002917PROCESS FOR THE PREPARATION OF ORTHO-HALOGENATED PHENYLALANINE COMPOUNDSDecember 2022February 2026Allow3800NoNo
17923885PROCESS FOR PREPARING ACRYLIC ACIDNovember 2022July 2025Allow3200NoNo
17922984METHOD FOR RECOVERING HEAVY BY-PRODUCTS FROM ACRYLIC ACID AND ESTERS OF SAID ACID BY THERMAL CRACKING WITH PARTIAL CONDENSATIONNovember 2022January 2026Abandon3810NoNo
17996534METHOD FOR OPERATING A PLANT FOR CONTINUOUS PRODUCTION OF AN ISOCYANATEOctober 2022July 2025Allow3300NoNo
17934099METHOD FOR PURIFYING AN ALKYLENE GLYCOL MONOALKYL ETHER CARBOXYLIC ACID ESTER HAVING HIHG-PURITY USED IN PHOTO RESIST PROCESSSeptember 2022September 2025Allow3601YesNo
17912975Compounds Comprising Perfluorinated Group, Photoinitiator Group, and Amide Linking GroupSeptember 2022December 2024Allow2711NoNo
17912203FORMATE PRODUCTION METHOD AND FORMATE PRODUCTION SYSTEMSeptember 2022March 2026Abandon4211NoNo
17930717One Pot Synthesis of Urea (Meth)AcrylatesSeptember 2022March 2025Allow3001NoNo
17796026Composite Material Including COF, Heat Dissipation/Storage Member, and Method for Producing Said Composite Material, and COF Single Crystal and Production Method ThereforJuly 2022October 2025Allow3831NoNo
17616912SYSTEM AND METHOD FOR PRODUCING DIESTER-BASED COMPOSITIONJuly 2022November 2025Allow4710YesNo
17613834PREPARATION METHOD FOR SALICYLAMINE ACETATEJune 2022March 2026Allow5120YesNo
17785748Separation Process and ApparatusJune 2022October 2025Allow4001YesNo
17746615ARYL TERPENE ESTERSMay 2022November 2024Abandon3031NoNo
17746624TERPENE ESTER SURFACTANTSMay 2022December 2024Abandon3131NoNo
17746626FATTY ACID TERPENE ALCOHOL ESTERSMay 2022November 2024Allow3031YesNo
17578417Method of Making a Magnesium Salt of an Alpha Keto Acid of Leucine, Isoleucine, and ValineJanuary 2022October 2025Abandon4510NoNo
17577222SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVESJanuary 2022January 2025Abandon3640NoNo
17625672METHOD FOR REDUCING THE CONCENTRATION OF SO3 IN A REACTION MIXTURE COMPRISING METHANE SULFONIC ACID AND SO3January 2022August 2025Allow4410YesNo
17625054N-FORMYLHYDROXYLAMINES AS NEPRILYSIN (NEP) INHIBITORS, IN PARTICULAR AS MIXED AMINOPEPTIDASE N (APN) AND NEPRILYSIN (NEP) INHIBITORSJanuary 2022February 2026Allow4911NoNo
17621840PROCESS FOR DISTILLATIVE PURIFICATION OF UNSATURATED CARBOXYLIC ANHYDRIDESDecember 2021October 2025Allow4620YesNo
17621043CATALYTIC DEPOLYMERIZATION OF LIGNIN TO HIGH VALUE HYDROCARBONSDecember 2021December 2025Abandon4820NoNo
17596380PROCESS FOR THE PRODUCTION OF PEROXYESTERSDecember 2021September 2024Allow3300YesNo
17616911ISOMERIZATION OF POLYUNSATURATED NON-AROMATIC COMPOUNDSDecember 2021February 2026Allow5020YesNo
17615787METHOD FOR PRODUCING DIESTER-BASED MATERIALDecember 2021March 2026Allow5130YesNo
17612237PROCESS AND REACTOR FOR PRODUCING PHOSGENENovember 2021November 2025Allow4821YesNo
17611811METHOD FOR PRODUCING LEVULINIC ACID IN MOLTEN SALT HYDRATE FROM CELLULOSE HYDROLYSISNovember 2021February 2025Abandon3910YesNo
17610761METHOD FOR PREPARING GLYCOLIC ACIDNovember 2021January 2025Abandon3801NoNo
17609441DIAMONDOID COMPOUNDSNovember 2021February 2025Allow3911YesNo
17609154METHOD FOR THE PURIFICATION OF ISOCYANATESNovember 2021January 2025Abandon3901NoNo
17604694PROCESS FOR THE PRODUCTION OF ANHYDROUS METHANESULFONIC ACID FROM METHANE AND SO3October 2021December 2024Allow3810YesNo
17603759METHODS FOR PRODUCING CRYSTALLINE L-GLUFOSINATE AMMONIUM MONOHYDRATEOctober 2021October 2024Allow3601NoNo
17603603SYNTHETIC METHODS OF PREPARING ESKETAMINEOctober 2021July 2024Allow3300NoNo
17603488NOVEL ENOL-ACETATES(II)October 2021December 2024Abandon3810NoNo
17602881PROCESS FOR SEPARATION OF SATURATED AND UNSATURATED CARBOXYLIC ACIDSOctober 2021December 2024Abandon3810NoNo
17494360CHEMOLYTIC UPGRADING OF LOW-VALUE MACROMOLECULE FEEDSTOCKS TO HIGHER-VALUE FUELS AND CHEMICALSOctober 2021January 2026Abandon5121NoNo
17601065METHOD FOR SYNTHESIS OF ORGANIC IODIDES, A PEROVSKITE-FORMING COMPOSITION COMPRISING AN ORGANIC IODIDE AND A PHOTOVOLTAIC CELL WITH A PEROVSKITE LAYER OBTAINED THEREFROMOctober 2021September 2024Allow3501YesNo
17442371RHEOLOGY ADDITIVES BASED ON HYDROXYLATED DI-OR TRI-AMIDES AND MIXTURES THEROFSeptember 2021September 2024Allow3601YesNo
17438518FLOW SYNTHESIS PROCESS FOR THE PRODUCTION OF OSELTAMIVIRSeptember 2021January 2025Allow4110YesNo
17472468PROCESS FOR PREPARING ETHYLENICALLY UNSATURATED COMPOUNDS CONTAINING URETHANE GROUPSSeptember 2021November 2024Abandon3810NoNo
17436983METHOD FOR PRODUCING FORMIC ACIDSeptember 2021October 2024Abandon3810NoNo
17443772SYSTEM AND METHOD FOR MANUFACTURING ESTER-BASED COMPOSITIONJuly 2021October 2025Abandon5140YesNo
17425833LUBRICATING BASE OIL SYNTHESIZED FROM SUGAR ALCOHOL ESTERSJuly 2021February 2026Abandon5531NoNo
17335821METAL DI-AMINO ACID CHELATES OR METAL TRI-AMINO ACID CHELATESJune 2021January 2025Abandon4311NoNo
17279200LYOPHILISATE OF TREOSULFANMarch 2021August 2024Allow4111YesNo
17267791NOVEL SULFONEUREA COMPOUNDSFebruary 2021October 2025Abandon5631YesNo
17265054PROCESSES AND CATAYLST SYSTEMS FOR PRODUCING MONOETHANOLAMINE FROM GLYCOLALDEHYDEFebruary 2021August 2024Allow4220YesNo
17155515METHOD FOR SEPARATION OF METHIONINE SULFOXIDE DIASTEREOMERSJanuary 2021December 2025Allow5931YesYes
16329132PROCESS FOR PREPARING SALICYLOYL-L-CARNITINE HYDROCHLORIDEFebruary 2019February 2020Allow1200NoNo
16269218ZWITTERIONIC SURFACTANT CONTAINING ETHOXYLATE UNITSFebruary 2019September 2019Allow800YesNo
16201087IMMOBILIZED METALLOPORPHYRIN CATALYST AND ITS UTILIZATION IN MALEIC ACID PREPARATIONNovember 2018September 2019Allow1001YesNo
16016693METHOD FOR PREPARING STABILIZER CONTAINING PHOSPHATE-ESTERJune 2018March 2019Allow800YesNo
16062195DOPED HYDRIDOSILANE COMPOSITIONS, AND METHOD FOR PRODUCING SAMEJune 2018March 2019Allow900YesNo
15781623NOVEL COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID COMPOUND, AND PHOTOSENSITIVE RESIN COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATORJune 2018August 2019Allow1510YesNo
15780718PROCESS TO PRODUCE A BIO-PRODUCTJune 2018October 2019Allow1711YesNo
15985596NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL SKIN DISEASEMay 2018April 2019Allow1120YesNo
15967463Method for preparing carboxylic esters from aldehydesApril 2018March 2020Allow2221YesNo
15851797Synthesis of Azelaic AcidDecember 2017May 2019Allow1710YesNo
15829008SELECTIVE AEROBIC OXIDATION OF DIMETHYLBIPHENYLSDecember 2017December 2018Allow1310YesNo
15552739P-TOLUIC ACID PRODUCING METHODAugust 2017August 2018Allow1100NoNo
15512595LIQUID THIOETHER CARBOXYLIC ACID ESTERSMarch 2017December 2018Allow2111YesNo
15320807METHODS FOR PRODUCING CHEMICAL PRODUCTS WITH OPERATION INTERRUPTIONSDecember 2016October 2019Allow3450YesNo
15320512PRODUCTION INTERMEDIATE OF POLYMERIZABLE COMPOUND, PRODUCTION METHOD FOR SAME, COMPOSITION, AND STABILIZATION METHODDecember 2016March 2018Allow1530NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner DOLETSKI, BLAINE G.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
1.4%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
1
Allowed After Appeal Filing
0
(0.0%)
Not Allowed After Appeal Filing
1
(100.0%)
Filing Benefit Percentile
1.4%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner DOLETSKI, BLAINE G - Prosecution Strategy Guide

Executive Summary

Examiner DOLETSKI, BLAINE G works in Art Unit 1692 and has examined 45 patent applications in our dataset. With an allowance rate of 71.1%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 38 months.

Allowance Patterns

Examiner DOLETSKI, BLAINE G's allowance rate of 71.1% places them in the 34% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by DOLETSKI, BLAINE G receive 1.29 office actions before reaching final disposition. This places the examiner in the 18% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by DOLETSKI, BLAINE G is 38 months. This places the examiner in the 29% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +56.7% benefit to allowance rate for applications examined by DOLETSKI, BLAINE G. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 32.1% of applications are subsequently allowed. This success rate is in the 67% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 30.0% of cases where such amendments are filed. This entry rate is in the 43% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 2% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 50.0% of appeals filed. This is in the 14% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 50.0% are granted (fully or in part). This grant rate is in the 46% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 3% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 4% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.